Dose-Optimization Study of 3 Starting Doses of Ponatinib: Long-Term Results From the OPTIC Trial

Autor: Cortes, Jorge, Deininger, Michael, Lomaia, Elza, Moiraghi, Beatriz, Undurraga Sutton, Maria, Pavlovsky, Carolina, Chuah, Charles, Sacha, Tomasz, Lipton, Jeffrey H., McCloskey, James, Hochhaus, Andreas, Rousselot, Philippe, Rosti, Gianantonio, de Lavallade, Hugues, Turkina, Anna, Maness, Lori, Talpaz, Moshe, Mauro, Michael, Lu, Vickie, Vorog, Alexander, Apperley, Jane
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S188-S188
Databáze: ScienceDirect
Externí odkaz: